MedTrace Logo

Depression and Heart Failure Disease Progression

NCT02131428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2022-01-10

No results posted yet for this study

Summary

Heart failure is the most costly diagnosis in the Medicare population. Clinical depression is strikingly common in heart failure patients, and not only diminishes their quality of life, but also is associated with a markedly increased risk of hospitalization or death. This study is designed to further our understanding of the behavioral and biological effects of depression in patients with heart failure, so that appropriate treatments can be developed.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Andrew Sherwood, PhD · Duke University

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131428 on ClinicalTrials.gov